FDA clears Candela's psoriasis treatment laser:
This article was originally published in Clinica
Candela has received US FDA 510(k) clearance to market its pulsed dye laser for the treatment of psoriasis, the second most common skin disorder in the US. The Wayland, Massachusetts company expects sales of the device to start later in the year.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.